Some GLP-1 drugs, like Ozempic and Rybelsus, are approved for treating type 2 diabetes, whereas Wegovy is approved for weight loss in individuals who are obese (with a body mass index or BMI of 30 or more) or who are overweight with a weight-related health condition
Archives of Pharmacal Research, 30(7), 834-839
These fatty acids are extremely susceptible to oxidative damage by free radicals or Reactive Oxygen Species (ROS) by a process called lipid peroxidation (LPO)
ARC, arcuate nucleus of the hypothalamus
Yes, GLP-1-based therapies are FDA-recommended for weight loss, particularly in individuals with a BMI over 30 or those who did not have success with other weight-loss methods
Dont settle for a transactional service that puts profits before people